Navigation Links
New Report Analyzes Key Controversies in Multiple Sclerosis Treatment

SCOTTSDALE, Ariz., Nov. 14 /PRNewswire/ -- MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for MS therapies.

In this report, entitled "MedPredict Thought Leader Insight & Analysis: Multiple Sclerosis," physician experts discuss the key controversies emerging from ECTRIMS (European Committee for Treatment and Research in MS) 2007, including:

-- Early aggressive therapy vs. more conservative approaches.

-- The negative results from REGARD, and implications for the powering of

MS trials. The report offers predictions on results expected in the


-- The potential for pulmonary delivery of interferon and Copaxone.

-- The numerous orally available drugs in development for MS. The report

reviews the benefits and drawbacks of fingolimod, other S1Ps,

short-acting VLA4, teriflunomide, laquinimod, fampridine, fumarates and

other oral options, and predicts where they will fall on the

safety/efficacy spectrum.

-- The status and potential of a number of vaccine approaches.

-- Intriguing neuroprotection / neuroregeneration strategies, including

LINGO, anti-myelin-associated-glycoprotein MAb and remyelination MAb.

Drugs/Mechanisms mentioned in this report include: S1P agonists (fingolimod; Novartis, S1P1; Roche/Actelion, Sphingomab; Lpath, S1P1 modulators; Epix / Amgen), inhibitors of DNA synthesis/repair (teriflunomide; Sanofi-Aventis, cladribine; Ivax/Serono), potassium channel blockers (fampridine; Acorda, BNC-245; Bionomics), interferons (Avonex; Biogen, Rebif; Ares-Serono, Betaseron; Bayer-Schering and Biferonex; Biopartners Holdings), VLA4 inhibitors (Tysabri; Biogen/Elan, firategrast; GlaxoSmithKline, CDP-323; UCB/Biogen; ATL1102 (Antisense Th

SOURCE MedPredict Market Research
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
(Date:10/9/2015)... 2015  DePuy Synthes Trauma* announced today the U.S. ... Technology**, the only pre-hydrated demineralized cancellous bone tissue ... and ankle, hand and wrist), including fusion, and for ... the 2015 Orthopaedic Trauma Association (OTA) Annual Meeting. ... new bone growth) and osteoinductive 2,3 (stimulates new ...
(Date:10/8/2015)... BEACH, Fla. , Oct. 8, 2015   ... in synthetic biology, today announced the appointment of ... of Environment Sector, succeeding Nir Nimrodi who ... Mr. Vaillancourt will direct Intrexon,s endeavors to generate sustainable, ... North America , where he held a variety ...
(Date:10/8/2015)... -- Celemics, a global pioneer of personalized medicine genetics, ... with the establishment of Celemics America, Inc. ... , has secured itself in the global market ... preparation for DNA sequencing and genetic testing.  Next Generation ... testing more accurately, quickly, and cost effectively than traditional ...
(Date:10/8/2015)... 2015  The ALS Association, in partnership with Prize4Life, ... to revolutionize communication technology solutions for people living with ... ALS (amyotrophic lateral sclerosis) is a progressive neurodegenerative disease ... the spinal cord. Eventually, people with ALS lose the ... leads to total paralysis and death within two to ...
Breaking Biology Technology:
... ), focused on discovering, developing and,commercializing treatments for diabetes and ... -- 18th Annual Wachovia Nantucket Equity Conference on Monday, ... (Eastern Time) at The White Elephant in Nantucket ... Conference on Thursday, June 26, 2008 ...
... and Advance,Healthcare, WASHINGTON, June 16 The ... Act (HIPAA) is having a,negative impact on the ... that benefit society, says a newly-released report by ... Barriers to,Research and Discovery describes the unintended disruptive ...
... ROCKVILLE, Md., June 16 Novavax, Inc.,(Nasdaq: NVAX ... Singhvi, President and Chief Executive Officer, will be presenting ... on June 24, 2008 at,The ANdAZ Hotel in London, ... strategy, research and development progress. A link to the ...
Cached Biology Technology:
(Date:10/7/2015)... , October 8, 2015 --> ... for Fingerprint Cards (FPC) during third quarter 2015 amounted to ... of around 860 MSEK that was communicated 20 August 2015. ... further strengthened delivery capacity and a continued growing demand for ... is estimated to be higher than during the third quarter. ...
(Date:10/6/2015)... , Oct. 6, 2015  Maverix Biomics, Inc., ... enhancements to its software portfolio with the debut ... for differential expression in eukaryotes. The software is ... a cloud-based genomic analysis solution that leverages proven ... from next-generation sequencing efforts. Garry Nolan,s ...
(Date:10/1/2015)... 2015  Biometrics includes diverse set of technologies ... such as fingerprints, eye retinas, facial patterns, voice ... technology has been constantly increasing in ... In addition to the most prominent popular method ... means of biometric authentication are rapidly gaining traction ...
Breaking Biology News(10 mins):
... global water crisis that already has left almost 800 million ... many more in the years ahead -- are the topic ... Chemical & Engineering News . C&EN is the weekly newsmagazine ... Alex Scott, C&EN,s senior editor for Europe, points out ...
... To make the inherent bitterness of cocoa in chocolate ice ... sugar. Yet, bitterness is an integral part of the complex ... August issue of the Journal of Dairy Science , ... form tolerate twice the amount of bitter ingredients in chocolate ...
... Mere months after porcine epidemic diarrhea virus (PEDV) ... University of Minnesota researchers have developed a PEDV rapid ... available now, provides a way to quickly and cost-effectively ... Characterized by acute diarrhea and vomiting, a PEDV outbreak ...
Cached Biology News:
Request Info...
... 1. 3500 V, 400 mA, 200 W ... linear voltage ramp modes.Linear voltage ramp mode ... strips quickly without danger of overheating.Volt-hour and ... thickness, sample ionic strength, and temperature.Stores and ...
MOUSE ANTI BOVINE CD335:ALEXA 488 Immunogen: Fusion protein consisting of the extracellular region of bovine CD335....
... Derivation Kit is intended for the ... delayed blastocysts in serum-free conditions. ... Clonal Grade Medium Basal ... Medium Trypsin Solution Gelatin Solution ...
Biology Products: